debrisoquin has been researched along with Substance-Related Disorders in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vesell, ES | 1 |
1 other study available for debrisoquin and Substance-Related Disorders
| Article | Year |
|---|---|
Pharmacogenetic approaches to the prediction of drug response.
Topics: Debrisoquin; Disease Susceptibility; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Re | 1986 |